戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              SPARC (Secreted Protein Acidic and Rich in Cysteine), is
2                                              SPARC (secreted protein acidic rich in cysteine) is an a
3                                              SPARC and myocilin mRNA expression were dramatically inc
4                                              SPARC and myocilin protein expression paralleled changes
5                                              SPARC binding does not distort the canonical triple heli
6                                              SPARC deficiency resulted in endoglin-mediated blockade
7                                              SPARC enhanced signaling by integrin-linked kinase (ILK)
8                                              SPARC expression in human adipose tissue correlated with
9                                              SPARC expression is increased in ACC samples by 1.56 +/-
10                                              SPARC expression was correlated with leptin independent
11                                              SPARC expression was measured by immunoblot.
12                                              SPARC in the stroma, but not in the tumor, was correlate
13                                              SPARC interacted directly with endoglin and reduced endo
14                                              SPARC is a matricellular protein often associated with f
15                                              SPARC is a matricellular protein that is highly expresse
16                                              SPARC is a matricellular protein that is involved in bot
17                                              SPARC is a regulatory node for IOP.
18                                              SPARC is known to be upregulated in the tumor microenvir
19                                              SPARC is not synaptogenic, but specifically antagonizes
20                                              SPARC is secreted at high levels by pancreatic stellate
21                                              SPARC is thus a novel regulator of microglial proliferat
22                                              SPARC levels were positively correlated with GSIS in isl
23                                              SPARC may be a downstream regulatory node of TGF-beta2-m
24                                              SPARC null/CX3CR1-GFP reporter mice reveal that SPARC re
25                                              SPARC overexpression decreased STAT3 phosphorylation; co
26                                              SPARC overexpression increased the IOP of perfused human
27                                              SPARC overexpression increases IOP in perfused cadaveric
28                                              SPARC production peaks when innervation of the rat super
29                                              SPARC recognizes the GVMGFO motifs of the middle and tra
30                                              SPARC reduced carcinogen-induced inflammation and accumu
31                                              SPARC retarded the morphological changes exhibited by pr
32                                              SPARC was expressed at measurable levels in human islets
33                                              SPARC was suppressed 31 +/- 13% (n = 5, P < 0.0001) by s
34                                              SPARC was upregulated by TGF-beta2 in the human TM cells
35                                              SPARC-like 1 (SC1) is a member of the SPARC family of ma
36                                              SPARC-null animals develop cataracts associated with a d
37                                              SPARC-null mice demonstrate a lower IOP resulting from i
38                                              SPARC-null mice demonstrated a more uniform outflow patt
39                                              SPARC-null mice had a 23% decrease in IOP.
40                                              SPARC-null mice have a 15% to 20% decrease in intraocula
41                                              SPARC-null mice have lower intraocular pressure (IOP).
42                                              SPARC-null mice have lower IOPs than do their WT counter
43                                              SPARC-Related Modular Calcium Binding Protein-2 (Smoc-2)
44                                              SPARC/Osteonectin (SP/ON) is implicated in the regulatio
45 ly poorer results (rmse 1.29 (ABSOLV), 1.25 (SPARC), and 1.62 (KOWWIN) log units).
46 he hematopoietic system is normal, HSCs in a SPARC-deficient niche show an accelerated return to quie
47 f cell lysates revealed enhanced levels of a SPARC-integrin beta1 complex during stress.
48             Monoclonal antibodies revealed a SPARC-like fragment generated from hevin that was co-loc
49 in 6 (IL-6) and supplemented IL-6-abrogated, SPARC-mediated suppression of Notch signaling and expres
50 ene target of Etv1 by luciferase assays, and SPARC and ETV1 proteins co-localized in vivo.
51 l gray and white matter in both controls and SPARC nulls.
52                         Here, COSMOtherm and SPARC performed clearly better with an rmse of 0.35 and
53  and of lung metastasis mediators (FSCN1 and SPARC).
54 ecombinant leptin, insulin, and glucose, and SPARC mRNA and protein expression determined by Western
55                                    Hevin and SPARC are expressed by astrocytes in the superior collic
56 d two astrocyte-secreted proteins, hevin and SPARC, as regulators of excitatory synaptogenesis in vit
57 h regulation of relative levels of hevin and SPARC, astrocytes might control the formation, maturatio
58 tive models, ABSOLV, COSMOtherm, KOWWIN, and SPARC to calculate storage lipid-water partition coeffic
59 ese results identify hevin as a positive and SPARC as a negative regulator of synapse formation and s
60                     We conclude that SC1 and SPARC may share significant homology, but are likely to
61 sive nephrotoxic nephritis in SPARC(+/+) and SPARC(-/-) mice.
62 ediating detachment, cultured SPARC(+/+) and SPARC(-/-) podocytes were subjected to mechanical strain
63 ARC expression has prognosticative value and SPARC is a potential therapeutic target for AML.
64        Passive microbead affinity for WT and SPARC-null ECM did not differ.
65                  Eyes of C57BL6-SV129 WT and SPARC-null mice were injected with fluorescent microbead
66 e not significantly different between WT and SPARC-null mice.
67 nce of SPARC, age-matched wild-type (WT) and SPARC-null mice underwent either transverse aortic const
68      This may become clinically relevant, as SPARC inhibition and its protective effect on HSCs could
69 he data supporting this relationship between SPARC and nab-paclitaxel remain largely correlative at t
70         The mechanistic relationship between SPARC and TGF-beta2 in trabecular meshwork (TM) is unkno
71                              The link betwen SPARC stromal deficiency and enhanced myeloid cell expan
72 t with Lat-B dramatically downregulated both SPARC and myocilin on 75 kPa hydrogels.
73  by metabolic parameters in these cells, but SPARC expression was not detectable in beta cells.
74 NA levels were reduced by 4MU treatment, but SPARC and CSPG6 mRNA levels were unaffected.
75 ibronectin, and laminin were not affected by SPARC overexpression.
76 ic single-cell microcultures is inhibited by SPARC.
77 pression in IPF fibroblasts was regulated by SPARC-mediated activation of Akt, leading to inhibition
78 ke by J774A.1 macrophages and high uptake by SPARC(+) B16F10 melanoma cells).
79 and Anatomy's Role in Coronary Artery [CAD] [SPARC]; NCT00321399).
80                    In human prostate cancer, SPARC immunoreactivity is highest in metastatic lesions
81                           In leukemia cells, SPARC expression was mediated by the SP1/NF-kappaB trans
82                          Throughout the CNS, SPARC is highly localized in mature ramified microglia,
83                               In conclusion, SPARC triggers a cell-autonomous program of synapse elim
84                                 In contrast, SPARC was downregulated in CN-AML patients harboring mut
85 e had fewer excitatory synapses; conversely, SPARC-null mice had increased synaptic connections in th
86  stroke in the forelimb sensorimotor cortex, SPARC nulls demonstrate enhanced microgliosis in and aro
87 n primary prostate tumorigenesis, we crossed SPARC-null (SP(-/-)) with TRAMP (Transgenic Adenocarcino
88  for SPARC in mediating detachment, cultured SPARC(+/+) and SPARC(-/-) podocytes were subjected to me
89 ecreted protein acidic and rich in cysteine (SPARC) and collagen-I and induction of complement activa
90 ecreted protein acidic and rich in cysteine (SPARC) being one of the most significant ones.
91 creted protein, acidic and rich in cysteine (SPARC) family matricellular protein, during invasive pha
92 ecreted protein acidic and rich in cysteine (SPARC) has been implicated in multiple aspects of human
93 ecreted protein acidic and rich in cysteine (SPARC) is a matricellular protein known to regulate extr
94 ecreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that is important for
95    Secreted protein acidic rich in cysteine (SPARC) is a matricellular protein that modulates the act
96 ecreted protein acidic and rich in cysteine (SPARC) is important for the normal growth and maintenanc
97 ecreted protein acidic and rich in cysteine (SPARC) is up-regulated and expressed intracellularly in
98 ecreted protein acidic and rich in cysteine (SPARC) participates in the regulation of morphogenesis a
99 ecreted protein acidic and rich in cysteine (SPARC) plays a key role in post-synthetic procollagen pr
100 creted protein, acidic and rich in cysteine (SPARC) were among those substrates we biochemically conf
101 ecreted protein acidic and rich in cysteine (SPARC), a matricellular protein with counteradhesive pro
102 ecreted protein acidic and rich in cysteine (SPARC), a molecule produced by glial cells, is involved
103 ecreted Protein Acidic and Rich in Cysteine (SPARC), a protein involved in mammalian cardiac function
104 ecreted protein acidic and rich in cysteine (SPARC), although the data supporting this relationship b
105 ecreted protein acidic and rich in cysteine (SPARC), and CA19-9 levels in relation to efficacy.
106 creted Protein, Acidic and Rich in Cysteine (SPARC), originally discovered in bone as osteonectin, is
107 ecreted protein acidic and rich in cysteine (SPARC), which significantly stimulated the expression of
108 ecreted protein acidic and rich in cysteine (SPARC)-deficient mice exhibited decreased pericyte-assoc
109 reted Protein, Acidic, and Rich in Cysteine (SPARC)-null mice have a lower intraocular pressure.
110 ecreted protein acidic and rich in cysteine (SPARC).
111 ose tissue explants, while glucose decreased SPARC protein.
112                                   Decreasing SPARC expression using siRNA has been shown to decrease
113 dels revealed that tumor- and stroma-derived SPARC reduced tumor growth and metastasis through inhibi
114 ration by targeting CTGF which downregulates SPARC expression.
115  our approach improves contrast because each SPARC-targeting molecule delivers a large number of nano
116 ibroblasts that is characterized by elevated SPARC, giving rise to activated beta-catenin, which regu
117  can be rescued by the addition of exogenous SPARC.
118                         Similarly, exogenous SPARC prevents IGF-1-induced survival of primary mouse i
119 pper binding domain of SPARC is required for SPARC-mediated response to stress.
120               To establish a causal role for SPARC in mediating detachment, cultured SPARC(+/+) and S
121 h peptide 4.2, a 20-aa sequence derived from SPARC that mimics full-length protein effects.
122 es for alkyl PAHs deviated increasingly from SPARC log K(OW) values with increasing degree of alkylat
123                               Microglia from SPARC nulls also intrinsically proliferate at a greater
124         However, when we subject muscle from SPARC-deficient mice to an in vitro fatigue stimulation
125 oteoglycans - including fibulin, hemicentin, SPARC, agrin, and type XVIII collagen - are present in B
126 The matricellular SPARC family member hevin (SPARC-like 1/SPARCL-1/SC1/Mast9) contributes to neural d
127  distribution of hevin in human TM and hevin/SPARC in mouse anterior segments.
128                            Furthermore, high SPARC promoter methylation negatively correlated with di
129        An adenoviral vector containing human SPARC was used to increase SPARC expression in human TM
130 ystal structure at 3.2 A resolution of human SPARC bound to a triple-helical 33-residue peptide harbo
131 nvasion of breast carcinoma cells identified SPARC, or secreted protein acidic and rich in cysteine.
132 4 integrin expression and signaling impacted SPARC expression and that SPARC facilitates beta4-mediat
133                           The data implicate SPARC in the noncell autonomous control of cardiac funct
134                                           In SPARC knockout mice, we performed an injury study to inv
135                                           In SPARC-null mice, TAC increased LV mass to an extent simi
136                              In addition, in SPARC-null mice, TAC increased fibrillar collagen conten
137 ations form an intramolecular salt bridge in SPARC and are essential for the binding of SPARC to coll
138        Collagen fibril diameter decreased in SPARC-null (28.272 nm) versus WT tissue (34.961 nm, P <
139                            PEFL increased in SPARC-null (70.61 +/- 11.36%) versus WT mice (54.68 +/-
140 e alpha-, beta-, and gamma-actin isoforms in SPARC knockout myoblasts reveals a changed expression pa
141  myocardial diastolic stiffness was lower in SPARC-null TAC mice (0.075+/-0.005) than in WT TAC mice
142 servations show that homozygous mutations in SPARC can give rise to severe bone fragility in humans.
143 by inducing passive nephrotoxic nephritis in SPARC(+/+) and SPARC(-/-) mice.
144   Moreover, the preserved podocyte number in SPARC(-/-) mice correlates with reduced urinary levels o
145 ments suggest that aqueous turnover rates in SPARC-null mice are equal to if not greater than rates i
146 s ameliorated, and proteinuria is reduced in SPARC(-/-) mice as compared with SPARC(+/+) littermates.
147 ion of the SP1/NF-kappaB complex resulted in SPARC downregulation and leukemia growth inhibition.
148 IV, we identified two homozygous variants in SPARC (GenBank: NM_003118.3; c.497G>A [p.Arg166His] in i
149  containing human SPARC was used to increase SPARC expression in human TM endothelial cells and perfu
150                                    Increased SPARC can be detected in the serum of type 2 diabetes pa
151 d that leptin and insulin potently increased SPARC production dose dependently in visceral adipose ti
152 ture amoeboid myeloid precursors only induce SPARC expression after they cease proliferation and migr
153                            TGF-beta2-induced SPARC expression was suppressed by inhibitors against p3
154                                   In islets, SPARC expression is highest in young mice, and is also e
155 kers, including laminin, J6(Hsp 47), and J31(SPARC, osteonectin) were expressed at lower levels in RA
156  capacity of this CRAd is driven by a 0.5-Kb SPARC promoter fragment (named F512).
157                      While podocytes lacking SPARC were more resistant to stretch-induced detachment,
158 oss induced by very-low-calorie diet lowered SPARC expression by 33% and increased by 30% in adipose
159  subjects for analysis of metabolic markers, SPARC, and various cytokines (RT-PCR).
160           In WT mice, TAC increased LV mass, SPARC expression, myocardial diastolic stiffness, fibril
161                            The matricellular SPARC family member hevin (SPARC-like 1/SPARCL-1/SC1/Mas
162                                  We measured SPARC expression by qRT-PCR in human primary pancreatic
163 FBI), interaction with the microenvironment (SPARC), retinoic acid signaling (RBP1), and the response
164 capable of processing and thereby modulating SPARC, a protein implicated in bone metastasis and infla
165    The selected mRNAs (IL-6, IL-8, myocilin, SPARC [secreted protein, acidic and rich in cysteine], m
166                       The mRNAs of myocilin, SPARC, and MMP-3, which do not have AREs, were more stab
167                                    At night, SPARC-null mice also exhibited a blunted increase in IOP
168                               The absence of SPARC reduced pressure overload-induced alterations in e
169 olic function are affected by the absence of SPARC, age-matched wild-type (WT) and SPARC-null mice un
170 t SC1 does not compensate for the absence of SPARC.
171 in K in regulation of biological activity of SPARC in bone metastasis.
172                                The amount of SPARC secreted by skin fibroblasts was reduced in indivi
173 n TCP produced greater or similar amounts of SPARC and myocilin mRNA after Lat-B treatment.
174 n SPARC and are essential for the binding of SPARC to collagen type I.
175 nificantly reduced secretion and cleavage of SPARC.
176                            The complexity of SPARC family proteins is further revealed by the detecti
177 es including cancer, but the contribution of SPARC to malignant growth remains controversial.
178                                The degree of SPARC expression in BM stromal elements, including CD146
179 s segmental, and that transgenic deletion of SPARC causes a more uniform pattern that correlates with
180  indicated that the copper binding domain of SPARC is required for SPARC-mediated response to stress.
181 tein and the result of a gene duplication of SPARC.
182 herefore aimed to characterise the effect of SPARC on beta-cell function and features of diabetes.
183 S) in primary human islets and the effect of SPARC overexpression on GSIS in beta cell lines.
184                   The profibrotic effects of SPARC may contribute to metabolic dysregulation in obesi
185 gether, our data indicate that evaluation of SPARC expression has prognosticative value and SPARC is
186                   Furthermore, expression of SPARC decreased the production of interleukin 6 (IL-6) a
187 -induced detachment, stable re-expression of SPARC restored detachment rates to levels comparable wit
188 ned therapy attenuates in vivo expression of SPARC, increases microvessel density, and enhances drug
189 F silencing also decreased the expression of SPARC, phospho-FAK and FAK and overexpression of SPARC a
190 -regulated DNMTs and increased expression of SPARC, which led to tumor growth suppression in bone in
191 hs post-instillation to assess the impact of SPARC on multiple stages in the development of fibrosis.
192 tion, an effect which appears independent of SPARC's modulation of obesity-induced insulin resistance
193 Our results highlight a complex influence of SPARC over the stromal and hematopoietic BM response in
194 sminogen-mediated apoptosis by inhibition of SPARC or beta-catenin.
195 umor tissues, the frequency and intensity of SPARC expression were inversely correlated with disease-
196              During the day, the mean IOP of SPARC-null mice (n = 142, 16.9 +/- 2.4 mm Hg) was lower
197                                  The IOPs of SPARC-null mice, their corresponding wild-type (WT), and
198  injury study to investigate whether lack of SPARC would compromise the ability to repair muscle.
199 sa26(YFP);Cre;Etv1(fl/fl)) reduced levels of SPARC and hyaluronic acid in the stroma.
200              Our data suggest that levels of SPARC are reduced in islets from donors with diabetes an
201 tutively expressed increased basal levels of SPARC, plasminogen activator inhibitor-1 (PAI-1), and ac
202 wild-type littermates, we found that loss of SPARC accelerated the development of urothelial preneopl
203                                      Loss of SPARC was associated with an inflammatory phenotype of t
204 in Drosophila and suggest that modulation of SPARC gene expression may ameliorate cardiac dysfunction
205 C, phospho-FAK and FAK and overexpression of SPARC abrogated the inhibitory effect of CTGF silencing
206 w that adenoviral-mediated overexpression of SPARC cDNA (Ad-DsRed-SP) elevated the expression of the
207                            Overexpression of SPARC in cultured beta-cells resulted in a 2.4-fold incr
208 h signaling is suppressed in the presence of SPARC, as well as the Notch effector basic helix-loop-he
209 action increased secretion and processing of SPARC, as did co-cultures of bone marrow stromal cells w
210              The coincident up-regulation of SPARC and cathepsin K occurred both in vivo in experimen
211             We then examined the relation of SPARC with glucose stimulated insulin secretion (GSIS) i
212 ed to the stromal compartment reminiscent of SPARC.
213 ray data, confirmed the expected reversal of SPARC gene suppression after treating HT-29 cells with 5
214 nteraction with actin suggests a new role of SPARC during tissue remodeling.
215 is protective effect is not due to a role of SPARC in HSCs, but rather is due to its function in the
216 ow, and IOP, indicating a modulatory role of SPARC in IOP regulation.
217        Accordingly, we elucidate the role of SPARC in mediating experimental crescentic glomeruloneph
218                     To determine the role of SPARC in primary prostate tumorigenesis, we crossed SPAR
219                                  The role of SPARC in the in vivo lung response to crocidolite asbest
220 of this study was to investigate the role of SPARC in the regulation of beta cell growth and survival
221       The VWF-binding site overlaps those of SPARC (also known as osteonectin) and discodin domain re
222 eta4 ligation facilitates the translation of SPARC through a TOR-dependent mechanism.
223 6, P = 0.01 for mRNA), while upregulation of SPARC had no effect on TGF-beta2.
224 ving further support to the potential use of SPARC as a therapeutic candidate for medulloblastoma tre
225 g and/or activity of ILK, integrin beta1, or SPARC resulted in increased apoptosis of stressed LEC.
226 ar fragment approaches (EPISuite's KOCWIN or SPARC), poly parameter linear free energy relationship (
227 idolite asbestos in a series of wild-type or SPARC-null mice.
228 discriminates between hevin and its ortholog SPARC.
229 rotein, acidic, cysteine-rich (osteonectin) (SPARC) gene, which encodes a matricellular protein that
230 rophin, along with required binding partners SPARC/SPARCL1 and HSP90B, as key mediators of this chemo
231                                      Primary SPARC-deficient pericytes exhibited increased basal TGF-
232 es the stromal-derived matricellular protein SPARC as a novel regulator of islet survival and beta ce
233       We show that the matricellular protein SPARC contributes to the BM stromal response to myelopro
234 e implication of the multifunctional protein SPARC (Secreted protein acidic and rich in cysteine)/ost
235                                     Purified SPARC inhibits growth factor-induced signaling in both I
236 regulated tumor modulating genes GPX3, RBP1, SPARC, and TGFBI.
237                    Specifically, recombinant SPARC inhibited (a) adipocyte differentiation of stromal
238                            Finally, reducing SPARC gene dosage ameliorated the cardiomyopathy that de
239 is study demonstrate that beta4 can regulate SPARC expression and that SPARC is an effector of beta4-
240 c microglia rapidly downregulate and release SPARC at the lesion, concomitant with reactive, hypertro
241 n; constitutive expression of STAT3 reversed SPARC-mediated expression of neuronal markers.
242  of secreted protein, acidic, cysteine rich (SPARC), myocilin, angiopoietin-like factor (ANGPTL)-7, a
243     Secreted protein, acidic, cysteine-rich (SPARC) is a glycoprotein that binds to collagen type I a
244 , FBLN1, FHL1, FN, NKTR, OGN, PARVA, S100A6, SPARC, STC1 and ZEB1 proteins showed specific and varied
245                        Furthermore, secreted SPARC activated the integrin-linked kinase/AKT (ILK/AKT)
246 ings demonstrate that both tumor and stromal SPARC are limiting for primary prostate tumorigenesis an
247 istinct contributions of tumoral and stromal SPARC to tumorigenesis and progression are unclear.
248     To determine the contribution of stromal SPARC, we evaluated subcutaneous tumor growth of TRAMP c
249 tor: nongerminal center B cell-like subtype, SPARC (secreted protein, acidic, and rich in cysteine) <
250 f a specific microRNA (miR-29a) that targets SPARC and impedes invasion.
251 engineered to display a peptide that targets SPARC glycoprotein, which is overexpressed in various ca
252 signaling impacted SPARC expression and that SPARC facilitates beta4-mediated invasion.
253 beta4 can regulate SPARC expression and that SPARC is an effector of beta4-mediated invasion.
254 -) mice and BM chimeras, we demonstrate that SPARC contributes to the development of significant stro
255               These results demonstrate that SPARC promotes pericyte migration by diminishing TGF-bet
256                     Here we demonstrate that SPARC-deficient mice display higher resistance to serial
257 ct protein-protein interaction, we find that SPARC binds to actin.
258                                We found that SPARC deficiency in the radioresistant BM stroma compart
259                          Here, we found that SPARC overexpression is associated with adverse outcome
260                   Importantly, we found that SPARC was epigenetically silenced in aggressive cells by
261     Therefore, we tested the hypothesis that SPARC in human adipose tissue is influenced by glucose m
262       These data support the hypothesis that SPARC plays a key role in post-synthetic procollagen pro
263  on these observations, we hypothesized that SPARC expression is clinically relevant in AML.
264                         We hypothesized that SPARC overexpression would alter IOP by affecting extrac
265      We show using immunohistochemistry that SPARC is expressed by stromal cells within islets and ca
266                  These results indicate that SPARC is produced by benign and malignant compartments o
267       Taken together, this study proves that SPARC plays a causal role in mediating podocyte detachme
268                In this paper, we report that SPARC promotes pericyte migration by regulating the func
269                  We previously reported that SPARC expression significantly impairs medulloblastoma t
270                  We previously reported that SPARC was among the most upregulated genes in cytogeneti
271                        We have reported that SPARC-null mice accumulate significantly more fat than w
272 RC null/CX3CR1-GFP reporter mice reveal that SPARC regulates the distribution and branching of mature
273                             We now show that SPARC inhibits adipogenesis in vitro.
274                           Findings show that SPARC-induced neuronal differentiation can sensitize med
275                        Our data suggest that SPARC expression is predominant in subcutaneous fat and
276     Taken together, our results suggest that SPARC induces expression of neuronal markers in medullob
277  in bone in vivo These findings suggest that SPARC plays a key role in maintaining the dormancy of pr
278  model of pancreatic cancer, suggesting that SPARC influences pericyte behavior.
279  in myopathies, which together suggests that SPARC might serve a specific role within muscle cells.
280        The hypothesis for the study was that SPARC contributes to the regulation of intraocular press
281 n levels and patterns are not altered in the SPARC null mouse, suggesting that SC1 does not compensat
282 collagen that was soluble was greater in the SPARC-null TAC mice (14+/-2%) than in WT TAC mice (1+/-2
283  collagen that was insoluble was less in the SPARC-null TAC mice (86+/-2%) than in WT TAC mice (99+/-
284 portance of addressing the complexity of the SPARC family and provides a new framework to explain the
285        SPARC-like 1 (SC1) is a member of the SPARC family of matricellular proteins that has been imp
286                                    LM of the SPARC-null iridocorneal angle revealed morphology that i
287                                   Therefore, SPARC appears to be an important modulator of the actin
288 Hevin is expressed in TM but, in contrast to SPARC, does not appear to be regulated by TGF-beta2.
289                        In direct contrast to SPARC, however, FSTL-1 expression is reduced in pancreat
290 t activity, and have been directly linked to SPARC regulation.
291 creased STAT3 phosphorylation in response to SPARC expression.
292                        TGF-beta2 upregulates SPARC expression in human TM through Smad-dependent (Sma
293   We hypothesized that TGF-beta2 upregulates SPARC expression in TM.
294 ertrophic perilesion astrocytes upregulating SPARC.
295 e upregulated genes were SNAI2, FGFBP1, VIM, SPARC (osteonectin), and SERPINE1, while the downregulat
296      TGF-beta2 did not induce hevin, whereas SPARC expression was induced in a dose-dependent manner
297 d detachment rates to levels comparable with SPARC(+/+) podocytes.
298  reduced in SPARC(-/-) mice as compared with SPARC(+/+) littermates.
299 6-ring parent PAHs, and correlated well with SPARC octanol/water coefficients (K(OW)) (correlation co
300 nal and nocturnal IOPs of C57Bl/6x129SvJ WT, SPARC-null, and heterozygous mice were measured.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top